Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies
- PMID: 19120014
- DOI: 10.1134/s0006297908120018
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies
Abstract
Synthesis of cationic plastoquinone derivatives (SkQs) containing positively charged phosphonium or rhodamine moieties connected to plastoquinone by decane or pentane linkers is described. It is shown that SkQs (i) easily penetrate through planar, mitochondrial, and outer cell membranes, (ii) at low (nanomolar) concentrations, posses strong antioxidant activity in aqueous solution, BLM, lipid micelles, liposomes, isolated mitochondria, and cells, (iii) at higher (micromolar) concentrations, show pronounced prooxidant activity, the "window" between anti- and prooxidant concentrations being very much larger than for MitoQ, a cationic ubiquinone derivative showing very much lower antioxidant activity and higher prooxidant activity, (iv) are reduced by the respiratory chain to SkQH2, the rate of oxidation of SkQH2 being lower than the rate of SkQ reduction, and (v) prevent oxidation of mitochondrial cardiolipin by OH*. In HeLa cells and human fibroblasts, SkQs operate as powerful inhibitors of the ROS-induced apoptosis and necrosis. For the two most active SkQs, namely SkQ1 and SkQR1, C(1/2) values for inhibition of the H2O2-induced apoptosis in fibroblasts appear to be as low as 1x10(-11) and 8x10(-13) M, respectively. SkQR1, a fluorescent representative of the SkQ family, specifically stains a single type of organelles in the living cell, i.e. energized mitochondria. Such specificity is explained by the fact that it is the mitochondrial matrix that is the only negatively-charged compartment inside the cell. Assuming that the Deltapsi values on the outer cell and inner mitochondrial membranes are about 60 and 180 mV, respectively, and taking into account distribution coefficient of SkQ1 between lipid and water (about 13,000 : 1), the SkQ1 concentration in the inner leaflet of the inner mitochondrial membrane should be 1.3x10(8) times higher than in the extracellular space. This explains the very high efficiency of such compounds in experiments on cell cultures. It is concluded that SkQs are rechargeable, mitochondria-targeted antioxidants of very high efficiency and specificity. Therefore, they might be used to effectively prevent ROS-induced oxidation of lipids and proteins in the inner mitochondrial membrane in vivo.
Similar articles
-
An attempt to prevent senescence: a mitochondrial approach.Biochim Biophys Acta. 2009 May;1787(5):437-61. doi: 10.1016/j.bbabio.2008.12.008. Epub 2008 Dec 29. Biochim Biophys Acta. 2009. PMID: 19159610 Review.
-
A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects.Biochemistry (Mosc). 2007 Dec;72(12):1385-96. doi: 10.1134/s0006297907120139. Biochemistry (Mosc). 2007. PMID: 18205623 Review.
-
Prevention of cardiolipin oxidation and fatty acid cycling as two antioxidant mechanisms of cationic derivatives of plastoquinone (SkQs).Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):878-89. doi: 10.1016/j.bbabio.2010.03.015. Epub 2010 Mar 20. Biochim Biophys Acta. 2010. PMID: 20307489 Review.
-
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke).Biochemistry (Mosc). 2008 Dec;73(12):1288-99. doi: 10.1134/s000629790812002x. Biochemistry (Mosc). 2008. PMID: 19120015
-
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells.Biochemistry (Mosc). 2008 Dec;73(12):1300-16. doi: 10.1134/s0006297908120031. Biochemistry (Mosc). 2008. PMID: 19120016
Cited by
-
Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.Antioxid Redox Signal. 2015 Mar 10;22(8):686-729. doi: 10.1089/ars.2014.5952. Antioxid Redox Signal. 2015. PMID: 25546574 Free PMC article. Review.
-
Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders.Curr Neuropharmacol. 2023;21(5):1165-1183. doi: 10.2174/1570159X20666220830112408. Curr Neuropharmacol. 2023. PMID: 36043795 Free PMC article. Review.
-
Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cells.J Pharmacol Exp Ther. 2012 Sep;342(3):709-19. doi: 10.1124/jpet.112.195586. Epub 2012 Jun 1. J Pharmacol Exp Ther. 2012. PMID: 22661629 Free PMC article.
-
Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction.J Inherit Metab Dis. 2011 Apr;34(2):315-25. doi: 10.1007/s10545-010-9162-y. Epub 2010 Jul 29. J Inherit Metab Dis. 2011. PMID: 20668944 Free PMC article. Review.
-
Reactive Oxygen Species-Mediated Damage of Retinal Neurons: Drug Development Targets for Therapies of Chronic Neurodegeneration of the Retina.Int J Mol Sci. 2018 Oct 27;19(11):3362. doi: 10.3390/ijms19113362. Int J Mol Sci. 2018. PMID: 30373222 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical